Sentences with phrase «as effective vaccines»

This is despite the existence of lifesaving treatments and prevention measures, such as effective vaccines.

Not exact matches

They're doing this very strategically by trying to incorporate as much of the variability and mutational changes to make sure the vaccine is effective.»

In the battle against cervical cancer, can fewer injections of the vaccine be just as effective in adolescents?

The same vaccine for cholera is also effective against ETEC, and certain vaccines are available for children as young as two.

Given questions about how long the vaccine is effective for, she questioned the efficacy of giving shots to girls as young as 11 years old in parts of the world (such as the U.S.) where women regularly undergo safety Pap screening repeatedly over their lifetimes, saying that the chances of their contracting cervical cancer may be less than the «small» risks associated with the vaccine.

The vaccine is believed to be extremely effective at preventing HBV, as long as a person, in this case your baby, is immunized before contracting the virus.

«What that suggests is that this approach really gives us broad spectrum protection, and could serve as a basis for an effective pre-pandemic vaccine.»

To date, only six patients (including Menezes) for whom the vaccination strategy failed have survived, the first was 6 year - old Matthew Winkler from Ohio, who was bitten by a rabid bat in 1970 and developed symptoms after receiving a full course of the vaccine (prior versions of the rabies vaccine were not as effective as current formulations).

As new disease strains continue to develop, and globalization and travel make it easier to pass disease across geographical borders, the ability to whip up huge quantities of effective vaccine is becoming increasingly important.

This fashion faded in the 1960s as effective treatments, such as vaccines and antibiotics, became available and people became aware that sun exposure and sunburn during childhood were strong risk factors for developing skin cancer in later life.»

He pointed to the sudden rise in share prices for pharmaceutical firms working on Ebola vaccines as one type of economic spur to ensure that medicines are there in an emergency, along with WHO's capacity to «prequalify» drugs as safe and effective so that they can be sold more cheaply and widely.

One of the most crucial and elusive goals of an effective HIV vaccine is to stimulate antibodies that can attack the virus even as it relentlessly mutates.

Overall, pandemic influenza vaccines were found to be 73 per cent effective at preventing laboratory - confirmed influenza illness and 61 per cent effective at preventing hospitalisation in the population as a whole.

The results from the study could be used to help public health officials to plan a more effective response to future pandemics, such as rolling out vaccines at a much earlier time and targeting specific types of vaccines at different age groups.

«We are pleased to have demonstrated such a potent and durable immune response to the vaccine,» said the study's lead author, Sita Awasthi, PhD, a research associate professor of Infectious Diseases at Penn. «If found effective in clinical trials, the vaccine will have a huge impact on reducing the overall prevalence of genital herpes infections and could reduce new HIV infections as well, especially in high - burden regions of sub-Saharan Africa.»

These vaccines, however, are not effective against viruses — so one solution is selecting parent fish with virus - resistant traits to use as broodstock for salmon egg production.

This makes the development of an effective vaccine to protect against infection, as well as antiviral therapy to combat already - existing infections, particularly challenging,» says Dr. Grant Hansman, a virologist who leads the CHS Research Group on Noroviruses at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and Heidelberg University.

He adds that the findings, which are published in the online 26 September issue of Nature Medicine, may be applicable to other infectious diseases such as tuberculosis, for which no highly effective vaccine exists.

But scientific and economic obstacles have stymied the development of effective vaccines against many of the developing world's most deadly diseases, such as malaria and HIV as well as pneumococcus, the leading vaccine - preventable killer of children under the age of five.

«The option of rapidly creating a completely synthetic formulation that can be effective as a vaccine is an important addition to currently available vaccine strategies,» says Hidde Ploegh, an MIT professor of biology, a member of the Whitehead Institute, and an author of the paper, who added that it will be important to assess safety and cost.

The idea of using messenger RNA molecules as vaccines has been around for about 30 years, but one of the major obstacles has been finding a safe and effective way to deliver them.

The vaccine generated a pool of TH1 CD4 + T cells (also called helper T cells) that are necessary for an effective antibody response as well as a stable pool of CD8 + T memory cells.

As for people getting the flu anyway despite being vaccinated, admittedly the vaccines are not always 100 percent effective, so it is possible.

Current vaccines, which require experts to pick the flu strains that they believe are going to circulate in a given year, are typically 40 to 70 percent effective in the U.S., though in some years protection is as low as 20 percent.

Kang's primary research focuses on designing and developing effective vaccines against viral diseases such as influenza virus and RSV, but he partnered with a university and research institutes in South Korea that wanted international collaborative projects to study if ginseng can be used to improve health and protect against disease because of the potential benefit in fighting these viruses.

Recent studies have shown that locally made Chinese vaccines are less effective than imported versions, which cost five to 10 times as much.

He says that a vaccine like this one could be on the market as soon as it proved effective and safe.

Since then the vaccine has only become more controversial — especially after The New England Journal of Medicine published results on May 11 showing that the vaccine may not be as effective as was hoped.

NIBIB - funded researchers have developed a novel 3D vaccine that could provide a more effective way to harness the immune system to fight cancer as well as infectious diseases.

«In exploring why some parents do not have their child get the flu vaccine, we found that many parents do not believe that flu vaccine is as safe, effective or important as the other vaccines their children receive.»

Dr. Ronald Ellis, Editor - in - Chief of HV&I, comments HPV vaccine is one of the most highly effective vaccines, and one of only two vaccines (along with hepatitis B) that has been shown to prevent an infection that can result in cancer, as well as morbidity and mortality.

If it proves as effective in people as it is in mice, a vaccine could one day be given to cancer patients after surgery, radiation therapy, or chemotherapy to prevent tumors from regrowing.

«Taken together, these two studies suggest that the new scalable vaccine formulation is likely to prove as effective as the original formulation — which would make it the first protective TB vaccine in humans since BCG, which was introduced almost a century ago,» said Professor Ajit Lalvani, Director of the Tuberculosis Research Centre, National Heart and Lung Institute, Imperial College London and a member of the DAR - 901 development team.

Because the immune system mounts an inadequate protective response against HIV, an HIV vaccine most likely will not be as effective as proven vaccines used to control or end global outbreaks, such as yellow fever and polio vaccines, which are nearly 100 percent effective.

While a vaccine against the virus is recently available commercially, its effectiveness is limited as it is not effective against all the four dengue viral subtypes, and there are no alternative therapeutics yet.

«Today's vaccines are marketed to fish farms as necessary disease prevention and are even required by some insurance companies, but they are not nearly as effective as needed under real world conditions.»

With better understanding, they may be able to develop more sophisticated vaccines that can be effective against more pathogens — those that differ as a result of genetic variations.

Vaccines are widely recognized as one of the world's most successful and cost - effective health interventions.

HPV vaccines have been available since 2006 and act as effective tools to prevent cervical cancer.

«Our findings support PfSEA - 1 as a potential vaccine candidate, and we are confident that by partnering with our colleagues at the National Institutes of Health and other researchers focused on vaccines to prevent the parasites from entering red blood cells, we can approach the parasite from all angles, which could help us develop a truly effective vaccine to prevent this infectious disease that kills millions of children every year.»

As demonstrated by the breadth of clinical trial involvement shown above, CCIR members are testing the utility of immune checkpoint blockade in lymphoma (shown by Dr. Allison to be effective against melanoma), genetic engineering in cell therapy (e.g., CD19, CXCR2, TGF - β DNR), and TLR agonists or IL - 2 in vaccine formulations as well as some novel combination therapies, such as the infusion of tumor - reactive lymphocytes from HLA - matched donors who were vaccinated with a lymphoma idiotypAs demonstrated by the breadth of clinical trial involvement shown above, CCIR members are testing the utility of immune checkpoint blockade in lymphoma (shown by Dr. Allison to be effective against melanoma), genetic engineering in cell therapy (e.g., CD19, CXCR2, TGF - β DNR), and TLR agonists or IL - 2 in vaccine formulations as well as some novel combination therapies, such as the infusion of tumor - reactive lymphocytes from HLA - matched donors who were vaccinated with a lymphoma idiotypas well as some novel combination therapies, such as the infusion of tumor - reactive lymphocytes from HLA - matched donors who were vaccinated with a lymphoma idiotypas some novel combination therapies, such as the infusion of tumor - reactive lymphocytes from HLA - matched donors who were vaccinated with a lymphoma idiotypas the infusion of tumor - reactive lymphocytes from HLA - matched donors who were vaccinated with a lymphoma idiotype.

The virus itself will continue to mutate from year to year — a process referred to as antigenic drift — and over time it becomes less well matched to the vaccine strain, meaning that the antibodies you generate from getting the vaccine may be less effective in neutralizing the circulating virus.

As part of its work package 8 activities, UNIL - VFL is providing access to the expertise within its dedicated facility for adjuvant supply, vaccine formulation, and quality control of adjuvanted vaccines, so as to accelerate the optimisation and characterisation of stable and effective formulationAs part of its work package 8 activities, UNIL - VFL is providing access to the expertise within its dedicated facility for adjuvant supply, vaccine formulation, and quality control of adjuvanted vaccines, so as to accelerate the optimisation and characterisation of stable and effective formulationas to accelerate the optimisation and characterisation of stable and effective formulations.

With this comprehensive approach, TRANSVAC2 functions as a leverage and innovation catalyst between all stakeholders involved in vaccine R&D in Europe, and contributes to the development of effective products to address European and global health challenges.

The HVTN's mission is to fully characterize the safety, immunogenicity, and efficacy of HIV vaccine candidates with the goal of developing a safe, effective vaccine as rapidly as possible for prevention of HIV infections globally.

Members of the CSCB also collaborate on a variety of projects related to detecting, understanding and treating cancer, other diseases and clinical disorders, as well as projects on infectious disease and the development of new and more effective vaccines.

Applying the principles of infection control brought the epidemic under control but a concern for reemergence naturally or a deliberate release supported continuation of a vaccine development effort so as to have the knowledge and capability necessary for preparing and using an effective vaccine should a need arise.

The primary focus will be to work as a member of the team responsible for delineating the immune response against nairoviruses to aid effective vaccine design.

In the same session, Elizabeth Mittendorf, M.D., Ph.D., of MD Anderson Cancer Center, presented research suggesting that vaccines may be most effective in the adjuvant setting where there is minimal disease (such as after surgery).

By bringing together for the first time three of Europe's leading vaccine development and manufacture companies as well as top experts from academic institutions and small and medium - sized enterprises (SMEs), the project will ultimately accelerate the development and introduction of a new generation of safer, more effective vaccines.